Navigation Links
Lowering Risk of Breast Cancer Recurrence

A new class of drugs could reduce the risk of breast cancer recurrence in post-menopausal women. Exemestane is a third-generation aromatase inhibitor. Aromatase inhibitors are drugs that block the conversion of precursor molecules. In the case of breast cancer, aromatase inhibitors block the conversion of precursor molecules into various types of estrogenic compounds. //In a new study, coordinated through the National Surgical Adjuvant Breast and Bowel Project, researchers are studying exemestane to determine if it can further reduce the risk of breast cancer recurrence among post-menopausal women.

John Cole, M.D., from the Ochsner Clinic in New Orleans, explains the ovaries in post-menopausal women no longer make estrogen. However, estrogen is still produced from the adrenal glands and from fatty tissues. He says by using an aromatase inhibitor like exemestane, that small residual amount of estrogen is even further reduced. Dr. Cole says, "You're taking low estrogen and you're making it even lower. Now, why does that matter? Well, breast cancer cells that are hormone-sensitive can sense even those very small amounts of estrogen."

Patients are still being enrolled in the trial. Researchers across the country will enroll 3,000 postmenopausal women who have received at least five years of tamoxifen therapy. Dr. Cole says, "Tamoxifen is a different type of medication. It blocks the receptors for estrogens on cancer cells." He says previous studies show aromatase inhibitors are at least equivalent, if not superior, to tamoxifen. He says, "It seems as though lowering the estrogen levels is even more effective than blocking estrogen interaction with cells in post-menopausal patients."

Dr. Cole says, even after five years of cancer-free status, there still is an ongoing risk of breast cancer recurrence. He says about 20 percent of patients in some groups will have recurrences after five years. He tells Ivanhoe that this is the first trial of thi
'"/>




Page: 1 2

Related medicine news :

1. Lowering blood pressure beneficial for PAD patients
2. Multi-Drug Therapy Effective in Lowering Blood Pressure
3. Multi-Drug Therapy Found To Be More Effective in Lowering B.P
4. Almonds found To Be Effective In Lowering Cholesterol
5. Almonds As Effective As Certain Drugs In Lowering Cholesterol
6. Using Cholesterol Lowering Drugs Effectively
7. Lowering cholesterol with vegetables in your diet
8. Fibre Rich Food A Boon For Lowering Cholesterol
9. Dark Chocolate Is Helpful In Lowering Blood Pressure.
10. Plant – based Foods More Effective In Lowering Cholesterol
11. Plant – based Foods More Effective In Lowering Cholestero
Post Your Comments:
(Date:7/18/2008)...ersity of Pennsylvania School of Medicine have sho...familial Alzheimer,s disease disrupt the flow of c...ed PS1 and PS2 (presenilin 1 and 2), interact with...l compartment. , "The ,calcium dysregulation, hy...imer,s disease has been suggested by previous rese...
(Date:7/18/2008)...tion to develop an integrated, comprehensive, nati...of losing its status as the global health care lea...on of Academic Health Centers (AAHC, www.aahcdc.o... Macy, Jr. Foundation. , Out of Order, Out of Ti...ns that the nation is running out of time to ensur...
(Date:7/18/2008)...to chemotherapy drugs, sometimes abruptly, after a... to reduce tumors or hold them in check? Although...this occurs is all too familiar: patients relapse ...sistant. , A team of researchers at Cold Spring ...e genetic underpinnings of cancer therapy response...
(Date:7/18/2008)...- Baxa Corporation, a,Denver-based manufacturer of...ng, packaging, and administering medications, anno... health-system users of its software and,pharmacy ...UG for,electronic Baxa Users, Group, offers a vari...irtual ,community, for sharing pharmacy best pract...
Breaking Medicine News(10 mins):Health News:Calcium may be the key to understanding Alzheimer's disease 2Health News:Calcium may be the key to understanding Alzheimer's disease 3Health News:New report warns current policies will not avert health workforce crisis 2Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 2Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 3Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 4Health News:Baxa Corporation Launches New Electronic Users' Group Web Site 2
...n people worldwide suffer from Filarial infection ...iasis, where their legs resemble that of an Elepha...uchereria bancrofti, this is a threadlike worm The...es where they cause the blockage of the flow of ly...
...immunity that had lead to inability to curbing of ...may have genes that act likewise. Researchers from...that the FOXP3 gene may be responsible for the low...s of multiple sclerosis. Multiple sclerosis is a c...
...ty disorder is common in people who are into subst...t was conducted by National Institute on Drug Abus...,000 adults of USA. Antisocial personality disorde...hat is characterized by behavior that tends to man...
...thyroid cancer may be detectable using a blood tes...according to a study published by researchers at ...ter and Arthur G. James Cancer Hospital and Richa...re published June 21 online in the Journal of Clin...
Other Medicine News:Health News:Antibiotics help combat dangerous tropical disease 2Health News:Tumour marker for detecting early Recurrence of Thyroid cancer may be soon available 2
(Date:7/16/2008)...lif., July 16 /- MAP,Pharma...e positive results,from a Phase 2 study evaluating...MAP0004 in adult asthmatics were published in the .... MAP Pharmaceuticals is,developing MAP0004, an or...otential treatment for migraine., The study resul...
(Date:7/15/2008)... 15 /- Abeome Corporation, a,Georgia-... equity,investment by Cato BioVentures and a colla...act research and development organization. The inv...ued development of Abeome,s lead,ovarian cancer pr...proves the development of,monoclonal antibodies an...
(Date:7/15/2008)...pletion of Phase III Trials of Light Infusion Ther...orectal Cancer and Phase I/II and Phase ...E, Wash., July 15 /- Light Sciences O...loping Light Infusion Therapy(TM),(Litx(TM)) to tr...hat it,has raised $40.1 million in a Series C roun...
(Date:7/15/2008)...lysis of the Alzheimer,s Disease Market Now Availa..., WALTHAM, Mass., July 15 /- Decisio...nd advisory firms for pharmaceutical and,healthcar...,s decision to,discontinue the development of Flur...fying Alzheimer,s disease treatment becomes Elan/W...
Breaking Medicine Technology:MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 2MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 4Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic 2Light Sciences Oncology Raises $40.1 Million in Series C Financing 2Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimer's Drug After Flurizan's Discontinuation 2AMDLs First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou China 2287 1AMDLs First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou China 2287 2Avastin Approved in Europe for First Line Treatment of Patients With Advanced Kidney Cancer 2285 1Avastin Approved in Europe for First Line Treatment of Patients With Advanced Kidney Cancer 2285 2Avastin Approved in Europe for First Line Treatment of Patients With Advanced Kidney Cancer 2285 3UT Southwestern secures 245 million NIH grant for lupus research 1665 1UT Southwestern secures 245 million NIH grant for lupus research 1665 2Council for Responsible Nutrition Calls Proposed DHEA Legislation A Solution in Search of a Problem 8513 1Council for Responsible Nutrition Calls Proposed DHEA Legislation A Solution in Search of a Problem 8513 2
...y to use, one step, lateral flow rapid dipstick th...g the amount of follicle stimulating hormone ("FSH...rmed two days after the onset of menses (day 3 of ...use to a pregnancy test or an ovulation prediction...
...a wealth of benefits to healthcare professionals a...o measure a complete lipid profile and glucose, AL... per test cassette (6 minutes for hs-CRP). To vie...curacy, speed and broad menu of tests available fo...
The Lifestream Cholesterol Monitor provides you with a comprehensive tool to help you monitor your cholesterol as part of your wellness program. At a later date, you can purchase the other components
The Accu-Chek InstantPlus Meter is Roche Diagnostics' only compact meter that can perform cholesterol and glucose with the same system. This simple, CLIA-waived test provides total cholesterol result
Medicine Products: